This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Canine Parvovirus 2 Capsid Protein VP2 (CPV-2 VP2)
Product Overview
BioVenic's Recombinant Canine Parvovirus 2 Capsid Protein VP2 (CPV-2 VP2) is a recombinant protein expressed from E.coli expression system. Its predicted molecular weight is 64.7 kDa. It can be used for antibody production or for immunoassays.
Specifications
Target Information
Canine parvovirus infection is an extremely contagious disease triggered by canine parvovirus type 2 (CPV-2). This virus primarily targets the white blood cells and the gastrointestinal tract of dogs and other canids, including coyotes, wolves, and foxes. The virus's capsid protein self-assembles to form an icosahedral structure with T=1 symmetry, measuring approximately 22 nm in diameter. This capsid comprises 60 copies of two variants of the capsid proteins, VP1 and VP2. The major distinction between these two proteins is the presence of an N-terminal extension in the minor protein, VP1.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in distilled water 1:100 as stock solution. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
References
- Alexis, Véliz-Ahumada et al. "Molecular Analysis of Full-Length VP2 of Canine Parvovirus Reveals Antigenic Drift in CPV-2b and CPV-2c Variants in Central Chile." Animals vol. 11,8 2387. 12 Aug. 2021